• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

电子健康工具为大都市全科医疗中的房颤筛查、管理和指南推荐治疗提供结构化辅助:AF-SMART 研究。

eHealth Tools to Provide Structured Assistance for Atrial Fibrillation Screening, Management, and Guideline-Recommended Therapy in Metropolitan General Practice: The AF - SMART Study.

机构信息

1 Faculty of Medicine & Health The University of Sydney Australia.

2 Heart Research Institute Charles Perkins Centre The University of Sydney Australia.

出版信息

J Am Heart Assoc. 2019 Jan 8;8(1):e010959. doi: 10.1161/JAHA.118.010959.

DOI:10.1161/JAHA.118.010959
PMID:30590964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6405712/
Abstract

Background This eH ealth implementation study aimed to evaluate strategies to promote opportunistic atrial fibrillation ( AF ) screening using electronic screening prompts and improve treatment using electronic decision support ( EDS ) software. Methods and Results An electronic screening prompt appeared whenever an eligible patient's (aged ≥65 years, no AF diagnosis) medical record was opened in participating general practices. General practitioners and practice nurses offered screening using a smartphone ECG, with validated AF algorithm. Guideline-based EDS was provided to assist treatment decisions. Deidentified data were collected from practices using a data extraction tool. General practices (n=8) across Sydney, Australia, screened for a median of 6 months. A total of 1805 of 11 476 (16%) eligible patients who attended were screened (44% men, mean age 75.7 years). Screening identified 19 (1.1%) new cases of AF (mean age, 79 years; mean CHA DS - VAS c, 3.7; 53% men). General practitioners (n=30) performed 70% of all screenings (range 1-448 patients per general practitioner). The proportion of patients with AF who had CHA DS - VAS c ≥2 for men or ≥3 for women prescribed oral anticoagulants was higher for those diagnosed during the study: 15 of 18 (83%) for screen-detected and 39 of 46 (85%) for clinically detected, compared with 933 of 1306 (71%) patients diagnosed before the study ( P<0.001). The EDS was accessed 111 times for patients with AF and for 4 of 19 screen-detected patients. Conclusions The eH ealth tools showed promise. Adherence to guideline-based oral anticoagulant prescription was significantly higher in patients diagnosed during the study period, although the EDS was only used in a minority. While the proportion of eligible patients screened and EDS use was relatively low, further refinements may improve uptake in clinical practice. Clinical Trial Registration URL : www.anzctr.org.au . Unique identifier: ACTRN 12616000850471.

摘要

背景

这项电子健康实施研究旨在评估利用电子筛查提示促进机会性心房颤动(AF)筛查的策略,并利用电子决策支持(EDS)软件改善治疗效果。

方法和结果

只要符合条件的患者(年龄≥65 岁,无 AF 诊断)的病历在参与的全科医生诊所中打开,就会出现电子筛查提示。全科医生和执业护士使用智能手机心电图进行筛查,采用经过验证的 AF 算法。基于指南的 EDS 用于辅助治疗决策。使用数据提取工具从实践中收集去识别数据。澳大利亚悉尼的 8 家全科医生诊所进行了中位数为 6 个月的筛查。在 11476 名符合条件的就诊患者中,共有 1805 名(44%为男性,平均年龄 75.7 岁)接受了筛查。筛查发现 19 例(1.1%)新的 AF 病例(平均年龄 79 岁;平均 CHA2DS2-VASc 为 3.7;53%为男性)。全科医生(n=30)进行了所有筛查的 70%(每位全科医生范围为 1-448 名患者)。在研究期间诊断的患者中,CHA2DS2-VASc 男性≥2 分或女性≥3 分的 AF 患者服用口服抗凝剂的比例更高:18 例(83%)筛查发现,46 例(85%)临床发现,而在研究前诊断的 1306 例患者中,933 例(71%)服用了口服抗凝剂(P<0.001)。EDS 为 111 例 AF 患者和 19 例筛查发现的患者中的 4 例患者提供了服务。

结论

电子健康工具显示出前景。在研究期间诊断的患者中,基于指南的口服抗凝剂处方的依从性显著提高,尽管 EDS 仅在少数情况下使用。尽管筛查的合格患者比例和 EDS 的使用相对较低,但进一步的改进可能会提高临床实践中的使用率。

临床试验注册网址

www.anzctr.org.au。独特标识符:ACTRN12616000850471。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25fb/6405712/3144f4e2f0e7/JAH3-8-e010959-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25fb/6405712/c76f0107fbad/JAH3-8-e010959-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25fb/6405712/3144f4e2f0e7/JAH3-8-e010959-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25fb/6405712/c76f0107fbad/JAH3-8-e010959-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25fb/6405712/3144f4e2f0e7/JAH3-8-e010959-g002.jpg

相似文献

1
eHealth Tools to Provide Structured Assistance for Atrial Fibrillation Screening, Management, and Guideline-Recommended Therapy in Metropolitan General Practice: The AF - SMART Study.电子健康工具为大都市全科医疗中的房颤筛查、管理和指南推荐治疗提供结构化辅助:AF-SMART 研究。
J Am Heart Assoc. 2019 Jan 8;8(1):e010959. doi: 10.1161/JAHA.118.010959.
2
Atrial Fibrillation Screen, Management, and Guideline-Recommended Therapy in the Rural Primary Care Setting: A Cross-Sectional Study and Cost-Effectiveness Analysis of eHealth Tools to Support All Stages of Screening.农村初级保健环境中心房颤动筛查、管理和指南推荐治疗:支持筛查各个阶段的电子健康工具的横断面研究和成本效益分析。
J Am Heart Assoc. 2020 Sep 15;9(18):e017080. doi: 10.1161/JAHA.120.017080. Epub 2020 Aug 31.
3
Uptake of a primary care atrial fibrillation screening program (AF-SMART): a realist evaluation of implementation in metropolitan and rural general practice.初级保健心房颤动筛查计划(AF-SMART)的采用情况:对大都市和农村全科实践中实施情况的实际评估。
BMC Fam Pract. 2019 Dec 6;20(1):170. doi: 10.1186/s12875-019-1058-9.
4
Atrial Fibrillation Screen, Management And Guideline Recommended Therapy (AF SMART II) in the rural primary care setting: an implementation study protocol.心房颤动筛查、管理和指南推荐治疗(AF SMART II)在农村基层医疗环境中的应用:一项实施研究方案。
BMJ Open. 2018 Oct 31;8(10):e023130. doi: 10.1136/bmjopen-2018-023130.
5
Increasing screening for atrial fibrillation in general practice: the Atrial Fibrillation Self-Screening, Management And guideline-Recommended Therapy (AF Self-SMART) study.在全科医疗中增加心房颤动筛查:心房颤动自我筛查、管理和指南推荐治疗(AF Self-SMART)研究。
Med J Aust. 2023 Jan 16;218(1):27-32. doi: 10.5694/mja2.51803. Epub 2022 Dec 9.
6
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.一项针对65岁及以上人群检测心房颤动的系统筛查(针对性筛查和全人群筛查)与常规做法的随机对照试验及成本效益研究。SAFE研究。
Health Technol Assess. 2005 Oct;9(40):iii-iv, ix-x, 1-74. doi: 10.3310/hta9400.
7
Screening for atrial fibrillation during influenza vaccinations by primary care nurses using a smartphone electrocardiograph (iECG): A feasibility study.基层保健护士使用智能手机心电图(iECG)在流感疫苗接种期间筛查心房颤动:一项可行性研究。
Eur J Prev Cardiol. 2016 Oct;23(2 suppl):13-20. doi: 10.1177/2047487316670255.
8
Effectiveness of a nongovernmental organization-led large-scale community atrial fibrillation screening program using the smartphone electrocardiogram: An observational cohort study.非政府组织主导的使用智能手机心电图进行大规模社区心房颤动筛查计划的效果:一项观察性队列研究。
Heart Rhythm. 2018 Sep;15(9):1306-1311. doi: 10.1016/j.hrthm.2018.06.006. Epub 2018 Jun 8.
9
Impact of care coordination on oral anticoagulant therapy among patients with atrial fibrillation in routine clinical practice in Japan: a prospective, observational study.在日本常规临床实践中,以患者为中心的抗凝药物管理对心房颤动患者口服抗凝治疗的影响:一项前瞻性、观察性研究。
BMC Cardiovasc Disord. 2019 Oct 24;19(1):235. doi: 10.1186/s12872-019-1216-y.
10
Detection rate and treatment gap for atrial fibrillation identified through screening in community health centers in China (AF-CATCH): A prospective multicenter study.通过在中国社区卫生中心进行筛查发现的心房颤动检出率和治疗差距(AF-CATCH):一项前瞻性多中心研究。
PLoS Med. 2020 Jul 16;17(7):e1003146. doi: 10.1371/journal.pmed.1003146. eCollection 2020 Jul.

引用本文的文献

1
Considering User Experience and Behavioral Approaches in the Design of mHealth Interventions for Atrial Fibrillation: Systematic Review.考虑用户体验和行为方法在房颤 mHealth 干预设计中的应用:系统评价。
J Med Internet Res. 2024 Oct 4;26:e54405. doi: 10.2196/54405.
2
Opportunistic atrial fibrillation screening in primary care in Ireland: results of a pilot screening programme.爱尔兰初级保健中的机会性心房颤动筛查:一项试点筛查计划的结果。
Open Heart. 2024 May 9;11(1):e002563. doi: 10.1136/openhrt-2023-002563.
3
Lower-adherence direct oral anticoagulant use is associated with increased risk of thromboembolic events than warfarin.

本文引用的文献

1
Major progress in anticoagulant uptake for atrial fibrillation at last: does it translate into stroke prevention?心房颤动抗凝治疗终于取得重大进展:这能否转化为预防中风的效果?
Eur Heart J. 2018 Aug 21;39(32):2984-2986. doi: 10.1093/eurheartj/ehy487.
2
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018.澳大利亚国家心脏基金会以及澳大利亚和新西兰心脏学会:《2018年澳大利亚心房颤动诊断与管理临床指南》
Heart Lung Circ. 2018 Oct;27(10):1209-1266. doi: 10.1016/j.hlc.2018.06.1043.
3
A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation.
低依从性直接口服抗凝药物的使用与华法林相比,血栓栓塞事件的风险增加。
J Interv Card Electrophysiol. 2024 Jun;67(4):709-718. doi: 10.1007/s10840-023-01585-x. Epub 2023 Aug 9.
4
Increasing screening for atrial fibrillation in general practice: the Atrial Fibrillation Self-Screening, Management And guideline-Recommended Therapy (AF Self-SMART) study.在全科医疗中增加心房颤动筛查:心房颤动自我筛查、管理和指南推荐治疗(AF Self-SMART)研究。
Med J Aust. 2023 Jan 16;218(1):27-32. doi: 10.5694/mja2.51803. Epub 2022 Dec 9.
5
Trends in guideline implementation: an updated scoping review.指南实施趋势:更新的范围综述。
Implement Sci. 2022 Jul 23;17(1):50. doi: 10.1186/s13012-022-01223-6.
6
Design, effectiveness, and economic outcomes of contemporary chronic disease clinical decision support systems: a systematic review and meta-analysis.当代慢性病临床决策支持系统的设计、效果和经济结果:系统评价和荟萃分析。
J Am Med Inform Assoc. 2022 Sep 12;29(10):1757-1772. doi: 10.1093/jamia/ocac110.
7
Machine learning-based identification of risk-factor signatures for undiagnosed atrial fibrillation in primary prevention and post-stroke in clinical practice.基于机器学习的临床实践中未诊断的心房颤动一级预防和卒中后风险因素特征的识别。
Eur Heart J Qual Care Clin Outcomes. 2022 Dec 13;9(1):16-23. doi: 10.1093/ehjqcco/qcac013.
8
Use of a smartphone electrocardiogram to diagnose arrhythmias during exercise in athletes: a case series.使用智能手机心电图诊断运动员运动期间的心律失常:病例系列
Eur Heart J Case Rep. 2022 Mar 23;6(4):ytac126. doi: 10.1093/ehjcr/ytac126. eCollection 2022 Apr.
9
2021 Asia Pacific Heart Rhythm Society (APHRS) practice guidance on atrial fibrillation screening.2021年亚太心脏节律学会(APHRS)心房颤动筛查实践指南。
J Arrhythm. 2021 Dec 28;38(1):31-49. doi: 10.1002/joa3.12669. eCollection 2022 Feb.
10
Remote Screening for Atrial Fibrillation by a Federal Cardiac Monitoring System in Primary Care Patients in Russia: Results from the Prospective Interventional Multicenter FECAS-AFS Study.俄罗斯初级保健患者中联邦心脏监测系统的远程心房颤动筛查:前瞻性介入多中心 FECAS-AFS 研究结果。
Glob Heart. 2022 Jan 18;17(1):4. doi: 10.5334/gh.1057. eCollection 2022.
一项针对英格兰住院心房颤动相关卒中的 10 年研究及其与口服抗凝药物应用的关系。
Eur Heart J. 2018 Aug 21;39(32):2975-2983. doi: 10.1093/eurheartj/ehy411.
4
Atrial fibrillation: is there enough evidence to recommend opportunistic or systematic screening?心房颤动:是否有足够的证据推荐进行机会性或系统性筛查?
Int J Epidemiol. 2018 Oct 1;47(5):1372-1378. doi: 10.1093/ije/dyy111.
5
Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.心房颤动筛查:AF-SCREEN 国际合作研究报告。
Circulation. 2017 May 9;135(19):1851-1867. doi: 10.1161/CIRCULATIONAHA.116.026693.
6
Oral Anticoagulants Initiation in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort.心房颤动患者口服抗凝剂的起始治疗:基于人群队列的真实世界数据
Front Pharmacol. 2017 Feb 17;8:63. doi: 10.3389/fphar.2017.00063. eCollection 2017.
7
The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.塔斯马尼亚心房颤动研究:2011 - 2015年向直接口服抗凝剂的转变
Cardiovasc Ther. 2017 Jun;35(3). doi: 10.1111/1755-5922.12254.
8
Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark.丹麦 2005 年至 2015 年期间心房颤动患者口服抗凝剂使用增加:时间趋势。
Eur Heart J. 2017 Mar 21;38(12):899-906. doi: 10.1093/eurheartj/ehw658.
9
Improving stroke prevention therapy for patients with atrial fibrillation in primary care: protocol for a pragmatic, cluster-randomized trial.改善基层医疗中房颤患者的卒中预防治疗:一项实用的整群随机试验方案
Implement Sci. 2016 Dec 3;11(1):159. doi: 10.1186/s13012-016-0523-2.
10
Screening for atrial fibrillation during influenza vaccinations by primary care nurses using a smartphone electrocardiograph (iECG): A feasibility study.基层保健护士使用智能手机心电图(iECG)在流感疫苗接种期间筛查心房颤动:一项可行性研究。
Eur J Prev Cardiol. 2016 Oct;23(2 suppl):13-20. doi: 10.1177/2047487316670255.